Contrasting Revolutions Medical (OTCMKTS:RMCP) and Glaukos (NYSE:GKOS)

Glaukos (NYSE:GKOS) and Revolutions Medical (OTCMKTS:RMCP) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, dividends, profitability, analyst recommendations, valuation, institutional ownership and earnings.

Risk and Volatility

Glaukos has a beta of 1.08, meaning that its stock price is 8% more volatile than the S&P 500. Comparatively, Revolutions Medical has a beta of -0.43, meaning that its stock price is 143% less volatile than the S&P 500.

Earnings and Valuation

This table compares Glaukos and Revolutions Medical’s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Glaukos	$314.71 million	16.12	-$134.66 million	($2.78)	-36.35
Revolutions Medical	N/A	N/A	N/A	N/A	N/A

Revolutions Medical has lower revenue, but higher earnings than Glaukos.

Profitability

This table compares Glaukos and Revolutions Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Glaukos	-42.79%	-22.67%	-11.50%
Revolutions Medical	N/A	N/A	N/A

Analyst Ratings

This is a breakdown of current recommendations and price targets for Glaukos and Revolutions Medical, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Glaukos	0	2	7	0	2.78
Revolutions Medical	0	0	0	0	N/A

Glaukos presently has a consensus target price of $99.80, indicating a potential downside of 1.25%. Given Glaukos’ higher possible upside, equities research analysts plainly believe Glaukos is more favorable than Revolutions Medical.

Insider & Institutional Ownership

99.0% of Glaukos shares are held by institutional investors. 6.4% of Glaukos shares are held by company insiders. Comparatively, 10.5% of Revolutions Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

Glaukos beats Revolutions Medical on 5 of the 9 factors compared between the two stocks.

About Glaukos

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent and iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.

About Revolutions Medical

Revolutions Medical Corporation, a development stage company, is engaged in the design, development, and commercialization of auto retractable vacuum safety syringes in the United States and internationally. The company develops RevVac auto retractable vacuum safety syringe, which is designed to reduce accidental needle stick injuries and lower the spread of blood borne diseases. It is also developing a suite of magnetic resonance imaging software tools consisting of RevColor, Rev3D, RevDisplay, and RevScan that are designed to enhance general diagnostic confidence through education and research use. The company sells its products to acute care hospitals, alternate care facilities, doctors' offices, clinics, emergency centers, surgical centers, convalescent hospitals, veterans administration facilities, military organizations, public health facilities, and prisons through distributors. Revolutions Medical Corporation was founded in 1996 and is headquartered in Charleston, South Carolina.